mutations and sophisticated kar yotype. It follows a linear evolution with the CLL clone throughout the recurrent acquisition of CDKN2ANot all individuals with CLL need therapy. Regardless of all recent innovations, the iwCLL still endorses watchful observation for individuals with asymptomatic condition.86 This advice is predicated on not less tha